The Latest Breaking News from Big Pharma

Here are just a few of the many examples of drug pricing practices that have driven consumers to demand change

The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face of the opioid epidemic: Purdue Pharma

The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments

If so, the network failed to enforce the supposed rule before and after cancelling its top-rated host.

Artificial intelligence can shave years off the development process, and companies like Japan’s Takeda are making large investments.

Some doctors, psychologists and eating disorder experts worry these new medications, originally developed to treat diabetes, could become a problem long-term.

Sally Susman is the author of "Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World."

The fentanyl crisis is hitting young people hard, and the highest death rates are in Native American communities. The Cherokee Nation is working to help young families recover.

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma.